openPR Logo
Press release

Know Facts of Middle East and Africa Precision Medicine Industry with, new developments, major strategies adopted by the well-known players such as Pfizer, Novartis, Teva Pharmaceutical Induistries etc.

01-24-2019 10:29 AM CET | Industry, Real Estate & Construction

Press release from: Research report hub

Know Facts of Middle East and Africa Precision Medicine Industry

Middle East and Africa Precision Medicine Market
The precision medicine market in the Middle East and Africa region is expected to grow at a significant because the adoption of IoMT and healthcare technologies has picked up over the last few years. Pharmaceuticals and biotech companies are trying to enhance medication and precision medicine solutions in the region Diagnostic companies are trying to improve the healthcare sector by adopting various technologies. The adoption of technologies like new-generation sequencing and gene therapy are creating opportunities for the growth of precision medicine market in the region. According to Netscribes, the Middle East and Africa precision medicine market is projected to expand at a compound annual growth rate (CAGR) of 9.96%, leading to a revenue of USD 2.51 Bn by 2023.

Download Free Report Sample (PDF) Here: https://www.researchreporthub.com/report/middle-east-and-africa-precision-medicine-market/11414/#requestforsample

The Middle East and Africa precision medicine market is classified into three primary segments: based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies); based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases); based on technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics).
Diagnostic companies hold the largest share in the segment for ecosystem players and are also expected to grow at the highest CAGR during the forecasted period of 2018-2023. Rising incidences of cancer globally implies that cancer therapeutics will be sought for its prevention as well treatment, because of which it will have the largest share of the therapeutics segment. Due to technological advancements, big data analytics is expected to grow at the highest CAGR with regard to technologies for precision medicine.

Key growth factors

In the African countries, the rising prevalence of diseases like HIV, malaria, tuberculosis, etc., warrant the use of precision medicine, which will in turn, propel the market. The Middle East population’s ability to afford precision medicine is another factor that can be attributed to its growth. Increasing demand for the customized medicine along with the adoption of technology in the region are driving the growth of precision medicine market.

Threats and key players

In the Middle East and African countries, out-of-pocket spending accounts for nearly half the total health-spending. Thus, many people have health insurance coverage, particularly in rural areas and among those who work in the informal sectors.
African countries have underdeveloped supply chains for medicines and often face challenges in maintaining an adequate medical workforce. One of the most pressing and unique challenges facing African healthcare systems is the shortage of adequately trained healthcare workers because of the lack of training programs, coupled with poor working conditions. These factors can hinder research and development in the precision medicine market.
The major players operating in the Middle East and Africa precision medicine market are Pfizer, Novartis, Teva Pharmaceutical Induistries etc.



Get Discount & Customization of this Report Here: https://www.researchreporthub.com/report/middle-east-and-africa-precision-medicine-market/11414/

Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: The Middle East and Africa precision medicine market - overview
2.1. Middle East and Africa market overview - market trends, drivers and challenges
2.2. Value chain analysis
2.3. Porter’s Five Forces analysis
2.4. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
2.4. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. d. Revenue from healthcare IT specialists/big data companies- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. Market size- by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
2.5. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Revenue from cardiovascular- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Revenue from central nervous system - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Revenue from psychiatric disorder- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. e. Revenue from infectious diseases- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market size - by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
2.6. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 3: The Middle East and Africa precision medicine market- by countries

3.1. The UAE
3.1.1. Market overview- market trends, drivers and challenges
3.1.2. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.1.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. Market size- By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.1.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. Market size- By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.1.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

3.2. Saudi Arabia
3.2.1. Market overview- market trends, drivers and challenges
3.2.2. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
3.2.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. Market size- By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
3.2.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. Market size- By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
3.2.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
………

Get Complete TOC with Figures and Tables Here: https://www.researchreporthub.com/report/middle-east-and-africa-precision-medicine-market/11414/#toc

Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.

Research Report Hub
20 Hanover Square
Mayfair, London W1S 1JY, UK
sales@researchreporthub.com
Web:www.researchreporthub.com
Find us on:
https://www.facebook.com/reasearchreporthub/
https://twitter.com/hub_report
https://www.linkedin.com/company/research-report-hub/

sales@researchreporthub.com
UK: +44 7441 906751
(US/CAN TOLL FREE):1 888-247-2308
Asia: +91 84484 44687

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Know Facts of Middle East and Africa Precision Medicine Industry with, new developments, major strategies adopted by the well-known players such as Pfizer, Novartis, Teva Pharmaceutical Induistries etc. here

News-ID: 1529019 • Views:

More Releases from Research report hub

Global Wine Market is Booming with Market Strategies Adopted By Key Players like E&J Gallo, The Wine Group, Constellation Brands, Castel, Accolade Wines.
Global Wine Market is Booming with Market Strategies Adopted By Key Players like …
Wine is an alcoholic drink produced by the fermentation of grapes or other fruits. Scope of the Report: The Wine industry concentration is very low; there are about many manufacturers or wineries in the world, and the products mainly from Italy, France, Spain, Australia and USA. Global manufactures mainly distributed in Europe, Australia and USA. The wineries in Europe have a long history and unshakable status in this field. Wineries in France relative
Global Microfiber Leather Market Emerging Trends and Prospects by leading Players, Kuraray, Toray, Asahi Kasei, Kolon Ind, Sanfang.
Global Microfiber Leather Market Emerging Trends and Prospects by leading Player …
Microfiber leather is a cross-industry product, its development of technology and application related to textiles, plastics, chemicals and other field. The main raw materials of microfiber leather are polyurethane pulp, low density polyethylene, nylon chips, etc. Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-microfiber-leather-market-2/47195/#requestforsample Scope of the Report: Microfiber Leather production are mainly concentrated in China and Japan at present, the output of this two regions occupy global production more than 80%. Microfiber leather production
Global Data Monetization Market 2018-2025 Growth Analysis by Key Players, Accenture, Viavi Solutions, Infosys, SAP.
Global Data Monetization Market 2018-2025 Growth Analysis by Key Players, Accent …
Data monetization, a form of monetization, is the act of generating measurable economic benefits from available data sources. Typically these benefits accrue as revenue or expense savings, but may also include market share or corporate market value gains. Data monetization leverages data generated through business operations, available exogenous data or content, as well as data associated with individual actors such as that collected via electronic devices and sensors participating in
Global Wireline Services Market Emerging Trends and Prospects by leading Players, Schlumberger, Halliburton, Baker Hughes, Weatherford.
Global Wireline Services Market Emerging Trends and Prospects by leading Players …
Wireline Service is the routine maintenance of a wellbore with wireline tools or any other devices so that well completion operations can be further worked upon. The service uses a cabling technology that a wireline service provider in oil and gas exploration and production business provides. This cabling technology together with the tools perform functions like intervening, pipe recovery and reservoir evaluation, etc. Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-wireline-services-market/47193/#requestforsample Scope of the

All 5 Releases


More Releases for USD

Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery? The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care. In 2025, the global bone cement market was valued at
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine? The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness. In 2025, the global autologous cell therapy
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population? The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare Introduction: PACS at the Core of Modern Medical Imaging The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making Introduction: The Growing Importance of HEOR in Modern Healthcare The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in